ACTA1 and keratitis: In summary, our data derived from the new murine model of LPS-induced keratitis demonstrate that topical application of HGF prevents the progression of keratitis-induced corneal opacity and inflammation by suppressing α-SMA and pro-inflammatory cytokine expression and restoring corneal architecture.